Supplementary Figure S1 from A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast CancerX. Cynthia, Matthew J. Ellis, Rama Suresh et al.|Unknown|2023Cited by 0
Data from A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast CancerX. Cynthia, Matthew J. Ellis, Jingqin Luo et al.|Unknown|2023Cited by 0